Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,476
Total Claims
$740K
Drug Cost
381
Beneficiaries
$1,943
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-88%
Opioid rate vs peers
0.3% vs 2.5% avg
+72%
Cost per patient vs peers
$1,943 vs $1,128 avg
+89%
Brand preference vs peers
15.9% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.3%
Opioid Rate
32
Opioid Claims
$280
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,635 claims · $621K
Generic: 8,640 claims · $113K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 111 | $64K |
| Linagliptin/Metformin Hcl | 72 | $63K |
| Levothyroxine Sodium | 612 | $55K |
| Linagliptin | 38 | $50K |
| Insulin Lispro | 80 | $48K |
| Rivaroxaban | 44 | $42K |
| Linagliptin/Metformin Hcl | 34 | $35K |
| Insulin Lispro Protamin/Lispro | 45 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 49 | $24K |
| Apixaban | 30 | $20K |
| Ticagrelor | 16 | $18K |
| Sitagliptin Phos/Metformin Hcl | 18 | $15K |
| Insulin Lispro | 27 | $14K |
| Dulaglutide | 11 | $11K |
| Insulin Nph Hum/Reg Insulin Hm | 29 | $9,617 |
Prescribing Profile
Patient Profile
71
Avg Age
60%
Female
2.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data